Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

175 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
IGF-I, IGF binding protein-3 and breast cancer risk: comparison of 3 meta-analyses.
Renehan AG, Egger M, Minder C, O'Dwyer ST, Shalet SM, Zwahlen M. Renehan AG, et al. Int J Cancer. 2005 Jul 20;115(6):1006-7; author reply 1008. doi: 10.1002/ijc.20975. Int J Cancer. 2005. PMID: 15723358 No abstract available.
Insulin-like growth factor-binding protein-3, breast cancer risk, and different serum assays.
Renehan A. Renehan A. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1844. doi: 10.1158/1055-9965.EPI-05-0214. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16030128 No abstract available.
Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
Renehan AG, Jones J, Potten CS, Shalet SM, O'Dwyer ST. Renehan AG, et al. Br J Cancer. 2000 Nov;83(10):1344-50. doi: 10.1054/bjoc.2000.1462. Br J Cancer. 2000. PMID: 11044360 Free PMC article.
The effect of cigarette smoking use and cessation on serum insulin-like growth factors.
Renehan AG, Atkin WS, O'dwyer ST, Shalet SM. Renehan AG, et al. Br J Cancer. 2004 Oct 18;91(8):1525-31. doi: 10.1038/sj.bjc.6602150. Br J Cancer. 2004. PMID: 15354219 Free PMC article.
Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides.
Renehan AG, Toogood AA, Ryder WD, Jones J, Potten CS, O'Dwyer ST, Shalet SM. Renehan AG, et al. Clin Endocrinol (Oxf). 2001 Oct;55(4):469-75. doi: 10.1046/j.1365-2265.2001.01380.x. Clin Endocrinol (Oxf). 2001. PMID: 11678829
Re: Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
Renehan AG, O'Dwyer ST, Shalet SM. Renehan AG, et al. J Natl Cancer Inst. 1999 Dec 1;91(23):2051-2. doi: 10.1093/jnci/91.23.2051. J Natl Cancer Inst. 1999. PMID: 10580038 No abstract available.
The development of composite circulating biomarker models for use in anticancer drug clinical development.
Lancashire LJ, Roberts DL, Dive C, Renehan AG. Lancashire LJ, et al. Among authors: renehan ag. Int J Cancer. 2011 Apr 15;128(8):1843-51. doi: 10.1002/ijc.25513. Int J Cancer. 2011. PMID: 20549702
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on.
Renehan AG, Harvie M, Howell A. Renehan AG, et al. Endocr Relat Cancer. 2006 Jun;13(2):273-8. doi: 10.1677/erc.1.01219. Endocr Relat Cancer. 2006. PMID: 16728563 Review.
Incident cancer burden attributable to excess body mass index in 30 European countries.
Renehan AG, Soerjomataram I, Tyson M, Egger M, Zwahlen M, Coebergh JW, Buchan I. Renehan AG, et al. Int J Cancer. 2010 Feb 1;126(3):692-702. doi: 10.1002/ijc.24803. Int J Cancer. 2010. PMID: 19645011
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.
Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Renehan AG, et al. Lancet. 2004 Apr 24;363(9418):1346-53. doi: 10.1016/S0140-6736(04)16044-3. Lancet. 2004. PMID: 15110491 Review.
175 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback